Whew! This is long title describing the remarkable results of a study, just announced at the American Heart Association’s meeting in New Orleans, which showed that AstraZeneca’s cholesterol fighting Crestor (rosuvastatin) slashed deaths, heart attacks, strokes, and artery-clearing procedures in apparently healthy patients who had normal cholesterol levels. The study has made a dramatic impression on some doctors who now expect an adjustment to preventive care guidelines.

More Information:

In yet another study of vitamin D, Reuters is reporting a study where scientists found that low vitamin D levels are associated with a higher risk for heart attack. 

Researchers studied medical records and blood samples from 454 men aged 40-75 who had either died from heart disease or who were alive but had a heart attack.